Detalles de la búsqueda
1.
A Three-Arm Randomized Controlled Study Comparing Patient-Reported Outcomes in People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections.
J Diabetes Sci Technol
; : 19322968241234055, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456441
2.
Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
BMC Fam Pract
; 13: 102, 2012 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23062116
3.
Diabetes management intervention studies: lessons learned from two studies.
Trials
; 22(1): 61, 2021 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461624
4.
Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.
J Diabetes Sci Technol
; 14(2): 240-249, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31378074
5.
Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.
Diabetes Res Clin Pract
; 144: 200-212, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30205184
6.
Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.
J Diabetes Sci Technol
; 10(3): 772-81, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26645793
7.
Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study.
J Clin Transl Endocrinol
; 1(4): 161-166, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29159096
8.
Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.
Diabetes Technol Ther
; 16(5): 310-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716820
9.
Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
Diabetes Care
; 36(11): 3613-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23900590
Resultados
1 -
9
de 9
1
Próxima >
>>